TrueBinding
Dongxu Sun is the Inventor of TrueBinding Platform and technologies with over 20 patents.
Dongxu Sun is also the Lead of novel drug target discoveries at Cornell, Cleveland Clinic, and ImmuNext.
This person is not in any offices
TrueBinding
TrueBinding is researching and developing first-in-class monoclonal antibody drugs to treat tumors, fibrotic diseases, metabolic diseases, autoimmune diseases, and neurologic diseases.